Certain medications may require predefined criteria before being approved for coverage. Other drugs may have daily or monthly limits recommended by the Food and Drug Administration, the drugs manufacturer, and/or  peer-reviewed medical literature. These instances may require a doctors request for preapproval or prior authorization.

 

The following guidelines, developed by Blue Cross and Blue Shield of Alabama's Pharmacy and Therapeutics Committee, are meant to help members understand the requirements related to their pharmacy coverage. Healthcare providers should use their best medical judgment in providing the care they feel is most appropriate for their patients.

 

Please note: Some employer groups may have specific drug coverage requirements for their employees that are not included in the criteria below.

 

For more information please review Physician Administered Drug Policies.

Search by Drug Name

Product Name Implementation Date Guideline
LANSOPRAZOLE The limits are 1 capsule or solutab per day.
LAZANDA® Prior authorization for medical necessity is required. The limits are 1 bottle per day.
LENVIMA® Prior authorization for medical necessity is required. Quantity limits are in place and vary based on strength.
LESCOL XL® Lescol XL may be subject to step therapy requirements. Patients must have trial and failure of generic statin (lovastatin, pravastatin, simvastatin).
LESCOL® Lescol may be subject to step therapy requirements. Patients must have trial and failure of generic statin (lovastatin, pravastatin, simvastatin).
LETAIRIS® Prior authorization for medical necessity is required.
LEVITRA® Prior authorization for medical necessity may be required. The limits are 8 tablets per 30 days. Patients must be at least 18 years of age.
LEVORPHANOL The limits are 4 tablets per day.
LEXIVA The limits are 4 tablets per 60 mL per day.
LEXXEL® Lexxel may be subject to step therapy requirements.
LINZESS® Prior authorization for medical necessity is required.
LIPITOR® Lipitor may be subject to step therapy requirements. Patients must have trial and failure of generic statin (lovastatin, pravastatin, simvastatin).
LIPTRUZET® Liptruzet may be subject to step therapy requirements. Patients must have trial and failure of generic statin (lovastatin, pravastatin, simvastatin).
LIVALO® Livalo may be subject to step therapy requirements. Patients must have trial and failure of generic statin (lovastatin, pravastatin, simvastatin).
LORCET® The limits are 6 tablets per day.

Affordable Care Act

Healthcare Reform Questions? Learn More

HealthQuotient®

What's your HQ Score? Get Started Now!